PHAS
Bank of America’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-193
| Closed | – | – | 7708 |
|
|
2022
Q3 | $0 | Hold |
193
| – | – | ﹤0.01% | 7428 |
|
|
2022
Q2 | $0 | Buy |
193
+192
| +19,200% | – | ﹤0.01% | 7690 |
|
|
2022
Q1 | $0 | Sell |
1
-298
| -100% | – | ﹤0.01% | 7959 |
|
|
2021
Q4 | $1K | Sell |
299
-5,197
| -95% | -$17.4K | ﹤0.01% | 7248 |
|
|
2021
Q3 | $17K | Sell |
5,496
-1,569
| -22% | -$4.85K | ﹤0.01% | 6540 |
|
|
2021
Q2 | $26K | Sell |
7,065
-15,105
| -68% | -$55.6K | ﹤0.01% | 6246 |
|
|
2021
Q1 | $77K | Buy |
22,170
+15,110
| +214% | +$52.5K | ﹤0.01% | 5812 |
|
|
2020
Q4 | $24K | Buy |
7,060
+1,393
| +25% | +$4.74K | ﹤0.01% | 5783 |
|
|
2020
Q3 | $20K | Sell |
5,667
-1,504
| -21% | -$5.31K | ﹤0.01% | 5626 |
|
|
2020
Q2 | $33K | Buy |
7,171
+3,038
| +74% | +$14K | ﹤0.01% | 5549 |
|
|
2020
Q1 | $14K | Sell |
4,133
-595
| -13% | -$2.02K | ﹤0.01% | 5659 |
|
|
2019
Q4 | $28K | Sell |
4,728
-746
| -14% | -$4.42K | ﹤0.01% | 5593 |
|
|
2019
Q3 | $22K | Buy |
5,474
+2,748
| +101% | +$11K | ﹤0.01% | 5727 |
|
|
2019
Q2 | $35K | Sell |
2,726
-1,124
| -29% | -$14.4K | ﹤0.01% | 5650 |
|
|
2019
Q1 | $37K | Buy |
+3,850
| New | +$37K | ﹤0.01% | 5546 |
|